Computer-delivered Screening & Brief Intervention for Marijuana Use in Pregnancy
Computer-based Screening, Brief Intervention, and Referral to Treatment (SBIRT) for Marijuana Use in Pregnancy: Planning a Stage II Trial
2 other identifiers
interventional
60
1 country
1
Brief Summary
Marijuana is by far the mostly commonly used illicit drug during pregnancy, and prenatal exposure to marijuana can have lasting negative effects. However, current answers to this problem are failing to reach most women who use marijuana while pregnant. This project will develop and begin testing two technology-based, highly practical interventions that could reduce the number of children who are prenatally exposed to marijuana.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Sep 2015
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
July 14, 2014
CompletedFirst Posted
Study publicly available on registry
July 16, 2014
CompletedStudy Start
First participant enrolled
September 30, 2015
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 20, 2017
CompletedStudy Completion
Last participant's last visit for all outcomes
October 27, 2017
CompletedResults Posted
Study results publicly available
July 3, 2018
CompletedJuly 3, 2018
June 1, 2018
1.6 years
July 14, 2014
May 1, 2018
June 4, 2018
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Number of Participants Abstinent From Marijuana for the 7 Days Prior to Delivery
Marijuana use will be measured at the time of delivery of their infant by self-report (TimeLine Follow Back interview - TLFB) and urine analysis. This will represent the number of participants who abstinent (reported no marijuana use and had a negative toxicology urine screen) from marijuana for the 7 days prior to delivery.
self-reported use during 7 days prior to delivery of their baby
Number of Participants Abstinent From Marijuana for the 90 Days Prior to Delivery
Marijuana use will be measured at the time of delivery of their infant by self-report (TimeLine Follow Back interview - TLFB) and hair toxicology analysis. This will represent the number of participants who were abstinent (reported no marijuana use and had a negative hair toxicology results) from marijuana for the 90 days prior to delivery.
self-reported use during 90 days prior to delivery of their baby
Study Arms (5)
electronic SBIRT (eSBIRT)
EXPERIMENTALParticipants in this condition will receive empathic exploration of their thoughts regarding marijuana use, provision of information on possible consequences of marijuana use during pregnancy and potential benefits of changing use (with permission), normed feedback, use of Motivational Interviewing techniques to elicit their own reasons for change, video testimonials modeling successful change, and information on change methods with optional goal setting.
Tailored texting
EXPERIMENTALParticipants in this condition will chose the frequency and time of text messages that will continue until childbirth or the participant opts out. The text messages will be a mix of marijuana targeted content (without directly referring to marijuana in a way that implies use by the participant) and general content related to healthy pregnancy; using appropriate humor and tips for community resources. Tailoring will focus on gestational age, self-efficacy, and social support.
eSBIRT & texting
EXPERIMENTALParticipants in this arm will receive both the computerized intervention and tailored text messaging intervention as described in the eSBIRT and Tailored texting arms.
Assessment only
NO INTERVENTIONParticipants in the arm will participant in screening and the baseline assessment conducted on the computer only. They will not receive an intervention.
Screening only
NO INTERVENTIONParticipants in this arm of the study will only answer the screening questions and will not be asked the baseline assessment or participate in an intervention.
Interventions
A single 20 minute interactive computer-delivered intervention designed to promote motivation to change prenatal marijuana use, without presuming the participant to be currently using marijuana while pregnant.
Group text messaging software from Trumpia, Inc. will be used to create the tailored text messages that will be sent to participants assigned to this intervention. Text messages will sent after the initial study participation visit until childbirth or participant opts out of receiving them.
Eligibility Criteria
You may qualify if:
- to 40 years of age
- weeks or less gestation
- intention to carry pregnancy to term
- self-reported marijuana use in month before pregnancy
- own a cell phone and willingness to receive text messages
- gives consent to access medical records for collection of birth outcome data
You may not qualify if:
- frank cognitive impairment or psychosis
- not able to communicate in English
- not planning to deliver at a Detroit Medical Center (DMC) hospital
- previous or current participant in a study conducted by Dr. Ondersma
- Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) Perinatal Research Branch participant.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Wayne State Universitylead
- National Institutes of Health (NIH)collaborator
- National Institute on Drug Abuse (NIDA)collaborator
Study Sites (1)
Wayne State University
Detroit, Michigan, 48202, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Results Point of Contact
- Title
- Dr. Jessica Beatty
- Organization
- Wayne State University, Merrill Palmer Skillman Institute
Study Officials
- PRINCIPAL INVESTIGATOR
Steven J Ondersma, PhD
Wayne State University
Publication Agreements
- PI is Sponsor Employee
- No
- Restrictive Agreement
- No
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor
Study Record Dates
First Submitted
July 14, 2014
First Posted
July 16, 2014
Study Start
September 30, 2015
Primary Completion
April 20, 2017
Study Completion
October 27, 2017
Last Updated
July 3, 2018
Results First Posted
July 3, 2018
Record last verified: 2018-06